Approval · Notice of Compliance 1014 · 2000
CASODEX: Notice of Compliance 1014
Issued February 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1014
- Date
- February 15, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Non-steroidal antiandrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CASODEX | 02184478 | Cancelled Post Market |
Medicinal ingredients
- BICALUTAMIDE 50 MG per TAB